Home/Pipeline/Comprehensive WGS/WES Diagnostic Service

Comprehensive WGS/WES Diagnostic Service

Rare Genetic Disorders

CommercialActive

Key Facts

Indication
Rare Genetic Disorders
Phase
Commercial
Status
Active
Company

About Arcensus

Arcensus is a privately held, revenue-generating diagnostics company focused on making whole genome sequencing a standard tool for physicians. It operates a CAP-accredited and ISO-certified laboratory, offering end-to-end services from sample logistics to clinical interpretation and reporting, primarily for rare genetic diseases. The company leverages a distributor-partner network to scale its reach and emphasizes data security and periodic data re-evaluation as key differentiators. Its strategic position aims to capitalize on the growing integration of genomics into routine clinical care.

View full company profile

Other Rare Genetic Disorders Drugs

DrugCompanyPhase
Platform Gene Therapy ApplicationsChimeron BioDiscovery
Rare Disease PlatformCongenicaCommercial